Skip to the page

Data / Drug companies / Doxorubicin hydrochloride

Doxorubicin hydrochloride: 20 companies and 62 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Doxorubicin hydrochloride is listed in the FDA National Drug Code Directory by 20 companies, with 62 products in commercial distribution. 47 of the products (75.8%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; injection, suspension, liposomal; injectable, liposomal, and the newest product started marketing on October 5, 2026.

The request: Get every company that lists doxorubicin hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
20
Products
62
Generic (ANDA) products
47 (75.8%)
Application numbers
16
Routes
Intravenous, Intravitreal
Brand names
Doxil
openFDA record search
api.fda.gov

Companies that list doxorubicin hydrochloride

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Hikma Pharmaceuticals USA Inc.10injection, solution; injection, powder, lyophilized, for solutionGeneric drugs (ANDA)January 19, 2018
Pfizer Laboratories Div Pfizer Inc10injection, solutionNew drug applications (NDA)March 31, 2025
BluePoint Laboratories7injectable, liposomal; injection, suspension, liposomalGeneric drugs (ANDA)October 5, 2026
Baxter Healthcare Corporation5injection, suspension, liposomalNew drug applications (NDA)August 26, 2024
Gland Pharma Limited3injection, solutionGeneric drugs (ANDA)August 22, 2017
Alembic Pharmaceuticals Inc.2injection, suspension, liposomalGeneric drugs (ANDA)June 27, 2025
Alembic Pharmaceuticals Limited2injection, suspension, liposomalGeneric drugs (ANDA)June 27, 2025
Dr. Reddy's Laboratories Inc.2injection, suspension, liposomalGeneric drugs (ANDA)June 27, 2025
Fresenius Kabi USA, LLC2injection, solutionGeneric drugs (ANDA)June 14, 2000
Lupin Pharmaceuticals, Inc.2injection, suspension, liposomalGeneric drugs (ANDA)August 26, 2024
NorthStar RxLLC2injectable, liposomalGeneric drugs (ANDA)May 29, 2019
Qilu Pharmaceutical Co., Ltd.2injection, suspension, liposomalGeneric drugs (ANDA)February 3, 2026
Sagent Pharmaceuticals2injection, suspension, liposomal; injection, solutionGeneric drugs (ANDA)March 1, 2026
Sun Pharmaceutical Industries, Inc.2injection, solutionGeneric drugs (ANDA)February 20, 2012
Sun Pharmaceutical Industries, Inc.2injectable, liposomalGeneric drugs (ANDA)February 5, 2013
Zydus Lifesciences Limited2injectable, liposomalGeneric drugs (ANDA)September 14, 2020
Zydus Pharmaceuticals USA Inc.2injectable, liposomalGeneric drugs (ANDA)September 14, 2020
Actavis Pharma, Inc.1injection, solutionGeneric drugs (ANDA)November 1, 2014
Amneal Pharmaceuticals LLC1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)February 17, 2017
Mylan Institutional LLC1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)February 27, 2014

Dosage forms

Dosage formProductsShare
Injection, solution2743.5%
Injection, suspension, liposomal1930.6%
Injectable, liposomal1219.4%
Injection, powder, lyophilized, for solution46.5%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)4775.8%
New drug applications (NDA)1422.6%
Unapproved drugs for a shortage11.6%

Pharmacologic classes

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.